Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial

Christopher Koh, Laëtitia Canini, Harel Dahari, Xiongce Zhao, Susan L. Uprichard, Vanessa Haynes–Williams, Mark A. Winters, Gitanjali Subramanya, Stewart Cooper, Peter A. Pinto,

The Lancet Infectious Diseases · 2015 · 263 citations · 25 references

DOIFull text

Open access

Concepts

References

25